Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

520 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison study.
Cassinotti A, Mezzina N, De Silvestri A, Di Paolo D, Lenti MV, Bezzio C, Stradella D, Mauri M, Zadro V, Ricci C, Casini V, Radice E, Massari A, Maconi G, Saibeni S, Caprioli F, Tari R, Fichera M, Cortelezzi CC, Parravicini M, Tinelli C, Testoni PA, Pace F, Segato S, Invernizzi P, Occhipinti P, Manes G, Di Sabatino A, Pastorelli L, Vecchi M, Ardizzone S. Cassinotti A, et al. Among authors: invernizzi p. Eur J Gastroenterol Hepatol. 2022 Dec 1;34(12):1238-1246. doi: 10.1097/MEG.0000000000002443. Epub 2022 Sep 23. Eur J Gastroenterol Hepatol. 2022. PMID: 36165081
Study of the influence of heme oxygenase 1 gene single nucleotide polymorphism (rs2071746) on esophageal varices among patients with cirrhosis.
Ellakany WI, Mahmoud MoheyEldin K, Invernizzi P, Mahmoud ElKady A, Eldin Fathy Abou Elkheir H, Abdel Haleem Abo Elwafa R, Ellakany A. Ellakany WI, et al. Among authors: invernizzi p. Eur J Gastroenterol Hepatol. 2018 Aug;30(8):888-892. doi: 10.1097/MEG.0000000000001161. Eur J Gastroenterol Hepatol. 2018. PMID: 29877949
Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study.
Mazza S, Piazza O Sed N, Conforti FS, Fascì A, Rimondi A, Marinoni B, Casini V, Ricci C, Munari F, Pirola L, Invernizzi P, Girelli C, Lupinacci G, Pastorelli L, Cavallaro F, Ferraris L, Colucci A, Amato A, Eugenio Tontini G, Vecchi M, Fiorino G, Caprioli F. Mazza S, et al. Among authors: invernizzi p. Clin Transl Sci. 2022 Jan;15(1):172-181. doi: 10.1111/cts.13131. Epub 2021 Sep 15. Clin Transl Sci. 2022. PMID: 34523800 Free PMC article.
Systematic review-pancreatic involvement in inflammatory bowel disease.
Massironi S, Fanetti I, Viganò C, Pirola L, Fichera M, Cristoferi L, Capurso G, Invernizzi P, Danese S. Massironi S, et al. Among authors: invernizzi p. Aliment Pharmacol Ther. 2022 Jun;55(12):1478-1491. doi: 10.1111/apt.16949. Epub 2022 May 3. Aliment Pharmacol Ther. 2022. PMID: 35505465 Free PMC article. Review.
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe.
Murillo Perez CF, Gerussi A, Trivedi PJ, Corpechot C, van der Meer AJ, Maria Battezzati P, Lindor KD, Nevens F, Kowdley KV, Bruns T, Cazzagon N, Floreani A, Tanaka A, Ma X, Mason AL, Gulamhusein A, Ponsioen CY, Carbone M, Lleo A, Mayo MJ, Dalekos GN, Gatselis NK, Thorburn D, Verhelst X, Parés A, Janssen HLA, Hirschfield GM, Hansen BE, Invernizzi P, Lammers WJ; GLOBAL PBC Study Group. Murillo Perez CF, et al. Among authors: invernizzi p. Eur J Gastroenterol Hepatol. 2023 Jan 1;35(1):112-119. doi: 10.1097/MEG.0000000000002464. Epub 2022 Nov 17. Eur J Gastroenterol Hepatol. 2023. PMID: 36468575
520 results